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Abstract Cyciosporin A sensitive swelling of mitochondria 
isolated from control mouse livers and from the livers of 
transgenic mice expressing human ubiquitous mitochondrial 
creatine kinase occurred in the presence of both 40 gM calcium 
and 5 gM atractyloside which was accompanied by a 2.5-fold 
increase over state 4 respiration rates. Creatine and cyclocrea- 
tine inhibited the latter only in transgenic liver mitochondria. 
Protein complexes isolated from detergent solubilised rat brain 
extracts, containing octameric mitochondrial creatine kinase, 
porin and the adenine nucleotide translocator, were reconstituted 
into malate loaded lipid vesicles. Dimerisation of creatine kinase 
in the complexes and exposure of the reconstituted complexes to 
200 gM calcium induced a cyclosporin A sensitive malate 
release. No malate release occurred with complexes containing 
octameric reatine kinase under the same conditions. 
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1. Introduction 
Mitochondrial permeability transition is a phenomenon 
that occurs during calcium loading of isolated mitochondria 
due to opening of an unspecific pore in the mitochondrial 
inner membrane, i.e. the permeability transition pore (PTP) 
(for reviews see [1,2]). PTP formation is enhanced by in- 
creased production of reactive oxygen species [3-6] and allows 
the flow of solutes < 1.5 kDa out from the mitochondrial 
matrix [3,7]. Opening of the pore may be involved in cellular 
apoptosis as a 50 kDa apoptosis inducing factor protein (AIF) 
is released from the mitochondrial intermembrane space 
(IMS), due to destruction of the mitochondrial outer mem- 
brane after excessive mitochondrial matrix swelling [8]. PTP 
manifestation is inhibited by substrates for the mitochondrial 
adenine nucleotide translocator (ANT), e.g. ADP and bonk- 
regic acid, or the immuno-suppressant drug cyclosporin A 
(CspA) [9 l l]. Recent publications have indicated that the 
PTP consists of either ANT alone [12,13], or a multi-protein 
complex consisting, in part, of hexokinase, porin and ANT 
[141. 
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An enzyme believed to have a structural and functional 
interaction with ANT is the mitochondrial isoform of creatine 
(Cr) kinase (CK; EC 2.7.3.2) (see [15] for review). CK is an 
enzyme involved in ATP homeostasis n cells of high and 
fluctuating energy demand and catalyses the following reac- 
tion: MgATP+Cr~ PCr+MgADP+H" . The mitochondrial 
isoforms of CK are the muscle specific sarcomeric Mi/,-CK, 
and the ubiquitous Mi,~-CK which is mainly found in brain 
tissue mitochondria. Mi-CK resides in the IMS, is believed to 
occur as an octamer in vivo [16] and has preferential ccess to 
ATP exported from the mitochondrial matrix by ANT [17,18]. 
The forward Mi-CK reaction (see above) keeps ANT satu- 
rated with ADP, which in turn has the effect of bringing 
mitochondria close to maximal state 3 respiration at relatively 
low ADP concentrations [17,18]. However, a structural inter- 
action between Mi-CK and ANT has not been demonstrated 
experimentally, so far. The dimeric cytosolic enzyme isoforms 
are also expressed in a tissue specific thshion and are cyto- 
plasmically compartmentalised [15], i.e, brain specific BB-CK, 
cardiac muscle specific heterodimeric MB-CK and the skeletal 
muscle cytosolic isoform MM-CK [15,17]. 
No CK isoform is expressed in mammalian liver, however 
new transgenic mice have been produced which express the 
BB-CK isoform specifically in their livers which has facilitated 
calculation of free ADP levels by :~P-NMR [19]. These mice 
have acquired resistance to induced hepatic insults, e.g. fruc- 
tose loading, major hepatectomy, ischaemia, hypoxia, as well 
as to endotoxins [20 23]. Another transgenic mouse has been 
developed in which the human Mi~-CK gene is specifically 
expressed in liver cells and imported successfully into the mi- 
tochondria of these cells [24]. Interestingly these Mi~-CK con- 
taining liver mitochondria were shown to contain IMS elec- 
tron densities, similar to those seen in Cr deficient rat solei 
[17] and Cr deficient adult rat cardiomyocytes [25]. Consider- 
ing that Mi-CK is proposed to interact with ANT,  and ANT 
may be a major component of the PTP [3,12 14], we induced 
PTP opening in control and transgenic liver mitochondria and 
quantitated the effects of the CK substrates PCr, Cr and the 
Cr analogues cyclocreatine (cycloCr) and guanidinopropionic 
acid (GPA) on PTP manifestation i control and transgenic 
liver mitochondria containing Mi-CK. In addition, we deter- 
mined the functionality of Mi~I-CK in relation to its coupling 
to ANT and oxidative phosphorylation (OXPHOS) in these 
mitochondria [17]. Finally, previously characterised isolated 
complexes from detergent solubilised rat brain extracts, 
known to contain porin, octameric Mi~-CK and ANT [14], 
were reconstituted into malate loaded vesicles. CspA sensitive 
malate release from these vesicles was used to analyse the role 
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of Mi~-CK in PTP opening or closing within the reconstituted 
complexes, in the presence of increasing concentrations of 
Ca 2+" 
2. Materials and methods 
2.1. Transgenic mice and creat&e analogue production 
Transgenic mice produced according to [24] were kindly provided 
on request by A.P. Koretsky. Guanidinopropionic a id and 1-car- 
boxymethyl-3-iminoimidazolidine (cyclocreatine) were produced ac- 
cording to [26,27]. 
2.2. Mitochondrial isolation 
Mice were killed and livers were immediately removed and placed 
into ice cold MSH buffer (210 mM mannitol, 70 mM sucrose, 5 mM 
HEPES, I mM EGTA, pH 7.4). The tissue was minced and washed 
with fresh MSH buffer until most of the blood was removed. Mito- 
chondria were isolated and further purified on a 20% Percoll gradient 
as described in [17]. Protein determinations were carried out according 
to [28]. 
2.3. Creatine kinase activity measurements 
Mitochondria of transgenic and control liver were analysed for 
creatine kinase activity in the pH-stat in 75 mM KC1, 10 mM MgC12, 
0.1 mM EGTA, 1 mM [3-mercaptoethanol and 4 mM ADP. The CK 
reaction was started upon addition of 10 mM PCr [29]. 
2.4. Spectrophotometry and oxygraph respirometry measurements of 
isolated liver mitoehondria 
CspA sensitive swelling of control and transgenic liver mitochon- 
dria (0.5 1 mg/ml in a buffer containing 40/aM CaCI2, 5 mM succi- 
nate, 20 mM Na2HPO4, 75 mM mannitol, 250 mM sucrose, 10 mM 
HEPES, pH 7.4) was induced by addition of 5/aM atractyloside (Atr). 
Absorption was monitored spectrophotometrically t 540 nm. De- 
creased absorption at 540 nm, due to mitochondrial swelling, is taken 
as an indicator of PTP opening [1]. 
Respiration measurements were carried out with isolated mitochon- 
dria from control and transgenic liver at 25°C, using a Cyclobios 
oxygraph (Anton Paar, Innsbruck, Austria) in respiration buffer (75 
mM mannitol, 250 mM sucrose, 10 mM HEPES, pH 7.4) [17]. Stim- 
ulation of state 4 respiration was carried out with 5 mM succinate and 
in the presence of 5 mM MgC12, 20 mM Na2HPO4. Low and max- 
imum state 3 respiration were stimulated with 25 /aM ADP followed 
by 50/aM ADP, respectively. This was repeated in the presence of 10 
mM Cr to analyse Mia-CK mediated stimulation of state 3 respiration 
[17,18]. Furthermore, after stimulating state 4 respiration (with 5 mM 
succinate), oxygen consumption caused by PTP formation was meas- 
ured first by introduction of 40/aM CaCI2 (final concentration) to the 
electrode chamber, followed by 5 /aM Atr. Additionally, measure- 
ments were also performed in the presence of CK substrates, i.e. 10 
mM Cr, PCr, cycloCr or GPA. To verify PTP opening 2 /aM CspA 
(Calbiochem) was added prior to the additions of 40 laM CaCI2 and 
5 /aM Atr. 
2.5. Reconstitution of complexes i olated from rat brains 
Rat brains, stored frozen, were homogenised with a Teflon potter in 
a medium composed of 10 mM glucose, 10 mM monothioglycerol, at 
pH 8. The membranes were washed 3 times by centrifugation for 15 
min at 12000×g. The complex was extracted from the final pellet by 
resuspension i  isolation medium containing 0.5% Triton X-100 and 
incubation for 45 min at room temperature. The undissolved mem- 
brane material was removed by centrifugation for 45 rain at 40 000 × g 
in a Beckman Ti 50 rotor. The supernate was stirred for 30 min at 
room temperature with diethylaminoethyl (DEAE) cellulose (DE52 
Whatman) that had been equilibrated with 1.5 mM Na2HPO4, 1.5 
mM K2HPO4, 1.0 mM dithioerythritol, 0.1 M glucose pH 8.0 (buffer 
A). The amount of DEAE cellulose used was 3 g per U of creatine 
activity. Mitochondrial creatine kinase was eluted from the column by 
a KCI gradient between 40 and 400 mM [14]. As shown recently [14] 
this fraction is also composed of porin and ANT. 
2.6. Reconstitution of the complexes into vesicles 
The complex fraction containing Mi-CK, ANT and porin was re- 
constituted in turkey egg yolk lecithin+2% cholesterol. The phospho- 
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lipid complex mixture was dialysed overnight against 10 mM HEPES 
pH 7.4. The vesicles were loaded with 5 mM malate by sonication, 
purified and freed of excess malate by subsequent chromatography on 
Sephadex G50 in 10 mM HEPES buffer. After chromatography the 
permeability of the loaded vesicles for malate was tested. Vesicles 
containing the protein complexes, and no protein as control, were 
centrifuged for 30 min at 400000×g and the supernate was tested 
for malate enzymatically [14]. 
2. 7. Dissociation of the creatine kinase in the complex 
Dissociation of octameric Mia-CK was performed according to [30] 
in the reconstituted liposomes and in aliquots of the DEAE cellulose 
column fractions by incubation of the samples for 20 min at room 
temperature with 5 mM MgC12, 20 mM creatine, 50 mM KNO3 and 
4 mM ADP (a mixture mimicking the transition state analogue com- 
plex or TSAC and known to dissociate octameric Mi-CK into dimers) 
[30]. The dissociation of the creatine kinase octamer was verified by 
Superdex 200 chromatography of the treated and untreated DEAE 
fractions. Malate loaded liposomes containing reconstituted octameric 
creatine kinase complex or dissociated dimeric creatine kinase com- 
plex were suspended in a buffer containing 125 mM sucrose, 10 mM 
HEPES (pH 7.4). The vesicles were analysed for malate release by 
addition of Ca 2+ between 0 and 400/aM in the presence or absence of 
0.5 /aM N-methylVal-4-cyclosporin (a gift from P. Bernardi to D. 
Brdiczka). 
3. Results and discussion 
3.1. Mitochondrial respiration analyses and spectrophotometry 
Transgenic liver mitochondria displayed 5.6+ 1.6 units of 
specific Mia-CK activity per mg of mitochondrial protein 
(n = 4), determined by the pH-stat assay [29]. No CK activity 
was measured in control iver mitochondria. We compared the 
rates of oxygen consumption due to coupled OXPHOS of 
control and transgenic liver mitochondria. As shown in Table 
1, under conditions of 25 and 50 ~tM ADP the transgenic mice 
showed slightly lower levels of oxygen consumption than con- 
trols. Consequently the transgenic liver mitochondria had a 
lower respiratory control ratio (RCR) than control, i.e. 3 and 
Table 1 
Rates of oxygen consumption (nmol O/mg mitochondrial protein/ 
min) by control and transgenic mouse mitochondria (n= 3) 
Substrate Control mitos Trans. mitos 
5 mM succ. 13+3 14 + 1.5 
25/aM ADP 33 + 1 28 + 1" 
50 JaM ADP 65 + 3 55 + 2 
RCR 4 3 
+10 mM creatine 
5 mM succ. 15+2 15.5+2 
25 /aM ADP 34+ 1 45.5+3* 
50/aM ADP 62 + 3 56 + 3 
Rates of oxygen consumption of control and transgenic (Trans.) 
mouse liver mitochondria (mitos) were carried out at 25°C with a 
Cyclobios oxygraph (Anton Paar, Innsbruck, Austria) in respiration 
buffer (75 mM mannitol, 250 mM sucrose, 10 mM HEPES, pH 7.4). 
Stimulation of OXPHOS was carried out in the presence of 5 mM 
MgC12, 20 mM Na2HPO4. State 4 respiration was the rate seen in the 
presence of 5 mM succinate only (succ.). Low state 3 was the rate of 
oxygen consumption seen after the addition of 25 /aM ADP, and 
maximal state 3 that observed in the presence of 50/aM ADP, with 
5 mM succinate already present. These experiments were repeated in 
the presence of 10 mM Cr to analyse Mia-CK mediated stimulation of 
state 3 respiration. Note that in mitochondria of transgenic mice ex- 
pressing Mia-CK in their livers (Trans. mitos), creatine stimulated 
respiration at 25 /aM ADP (*) relative to the values reached with 
the same ADP concentration. No comparable effect was observed in 
control mitochondria. 
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4, respectively (Table 1). In the presence of 10 mM Cr, 25 }aM 
ADP brought state 3 from 50% of maximum (as seen without 
Cr) to 80°/,, of maximal state 3 (Table 1), only in transgenic 
liver mitochondria. This stimulation of respiration by Cr via 
Mi-CK is normally found with isolated brain, skeletal and 
cardiac muscle mitochondria [17]. This clearly indicates that 
the Mi~-CK in the transgenic liver mitochondria is active and 
conveys Cr stimulated respiration to mitochondria. No such 
effect was seen in control liver mitochondria, as expected (Ta- 
ble 1). Gel permeation chromatography of transgenic liver 
mitochondria extracts confirmed the prevalence (>95%)  of 
octameric Mi-CK (data not shown). 
In control and transgenic liver mitochondria, swelling (in- 
dicative of PTP opening) was observed only after the addition 
of 5 }aM Atr to the mitochondrial suspensions containing 40 
I.tM Ca ~" (data not shown). No swelling was observed in the 
presence of 0.5 pM CspA. In the next set of mitochondrial 
experiments we measured the rates of oxygen consumption 
above state 4 (with 5 mM succinate) after the addition of 40 
}aM Ca 2~ followed by 5 }aM Atr. 40 }aM Ca ~+ alone induced a 
50-60% increase of state 4 oxygen consumption (Fig. 1), fur- 
ther addition of 5 }aM Atr led to a final 2.5-fold increase of 
state 4 oxygen consumption in both control and transgenic 
liver mitochondria (Fig. 1). 10 mM Cr or cycloCr inhibited 
this stimulation of OXPHOS observed with either 40 }aM 
Ca 2+ or 5 }aM Atr, only with transgenic mouse mitochondria 
(Fig. 1). Neither PCr nor GPA had any observable ffect on 
oxygen consumption rates under these conditions of control 
and transgenic liver mitochondria, under the same conditions. 
3.2. PTP-like properties in vesicles containing protein 
complexes i olated Jrom rat brain 
Experiments were carried out with previously characterised 
300 
• 40pM ~Cl2  
[ ]  40tJM CaCI2 + 5pM Atr 
100 
CM+C~^ CM TM+C.~A TM TM+Cr 7"M+l~q~r "rM-~'yCr "n~+opA 
Fig. 1. Histogram representing the rates of oxygen consumption as 
a percentage of state 4 (100%=state 4 with 5 mM succinate) in the 
presence of 40 laM CaCI2 followed by 5 gM atractyloside. 
CM=control liver mitochondria, TM=transgenic liver mitochon- 
dria, error bars indicate the standard deviation. All experiments 
were carried out at 25°C, with a Cyclobios oxygraph (Anton Paar, 
Innsbruck, Austria) in the respiration buffer (220 mM o-mannitol, 
70 mM sucrose, 10 mM HEPES, pH 7.4) and as indicated, in the 
presence of 2 gM cyclosporin A (+CspA), or 10 mM creatine 
(+Cr), 10 mM phosphocreatine, 10 mM cyclocreatine (+cyCr), 10 
mM guanidinopropionic a id (+GPA). It is evident hat 10 mM Cr 
and l0 mM cyclocreatine have a similar effect to 2 laM CspA by in- 
hibiting the 5 gM Atr stimulation of oxygen consumption after the 
addition of 40 pM CaC12. 
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Fig. 2. (A) The isolated complexes incorporated into liposomes were 
loaded with malate and treated with concentrations of Ca ~ from 
0 to 400 gM, and analysed for malate release (empty diamonds). 
These experiments were repeated after preincubation for 15 min at 
25°C of the vesicles with 500 nM N-methylVal-4-cyclosporin (CspA) 
plus the transition state analogue complex, i.e. 5 mM MgC12, 20 
mM creatine, 50 mM KNO:~ and 4 mM ADP (TSAC. inducing a 
Mi-CK dimer-octamer t ansition (filled triangles), or preincubated 
with TSAC alone, before exposure of isolated PTP complexes to the 
increasing calcium concentrations (empty circles). Note that dimer- 
isation of Mi-CK led to maximal malate release (permeability tran- 
sition-like pore opening). (B) The dissociation of the creatine kinase 
octamer was verified by Superdex 200 chromatography of the 
TSAC treated DEAE fractions. Nearly all the CK activity (filled 
circles) and protein (empty triangles), measured by absorption at 
280 nm, spectrophotometrically e uted in a peak representing a mo- 
lecular weight of approximately 80 kDa. Arrows indicate calibrated 
molecular weight elution volumes (ml). 
protein complexes isolated from rat brain [14], consisting of 
ANT, porin and octameric Mi~-CK. These complexes were 
reconstituted into malate loaded phospholipid vesicles and 
exposed to 0 400 }aM Ca 2-~ in the absence or presence of 
TSAC (to dimerise Mi-CK) (Fig. 2A). CspA sensitive malate 
release from the vesicles served as an indicator of PTP-like 
behaviour. Malate release was not observed upon loading of 
the vesicles with Ca 2+ ranging from 0 to 400 }aM (Fig. 2A). In 
contrast, treatment of the vesicles with TSAC caused a 6-fold 
increase of malate release in the presence of 400 }aM Ca 2+, 
over that seen without Ca 2+. In the presence of CspA plus 
TSAC, malate release was efficiently blocked (Fig. 2A). These 
results indicate that octameric Mi~-CK within the reconsti- 
tuted complexes is necessary for inhibition of permeability 
transition, without the addition of any CK substrate. TSAC 
induced dimerisation of Mi-CK was confirmed by gel perme- 
ation chromatography, revealing that all measurable CK ac- 
tivity eluted in a peak at a MW of 80 kDa, representing 
dimeric Mi~-CK (Fig. 2B). 
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4. Conclusion 
The results presented in this study reveal that human Mi~- 
CK expressed in the liver of transgenic mice behaves exactly 
as Mi~-CK does in isolated brain mitochondria, where it is 
most commonly expressed [17]. The spectrophotometric anal- 
yses of mitochondrial swelling as well as respiration measure- 
ments of control and transgenic liver mitochondria revealed 
that permeability transition only occurred in the presence of 
both 40 ~tM CaC12 and 5 gM Atr. This suggests that calcium 
cycling is responsible for the initial increased rate of oxygen 
consumption over state 4, but is insufficient to induce perme- 
ability transition. Such [Ca 2+] may have a priming effect of 
ANT in isolated mitochondria, which supports permeability 
transition in the presence of low levels of Atr (an ANT sub- 
strate), which has already been proposed [12]. The absence of 
EDTA or EGTA in our experiments explains the low amount 
of calcium and Atr necessary to induce permeability transi- 
tion, and why millimolar quantities of Atr were necessary in 
the experiments of the Kreomer group, which were carried out 
in the presence of the above chelating agents [1,8]. The respi- 
ration rate increases 2.5-fold over state 4 due to permeability 
transition, indicating a collapse of the mitochondrial inner 
membrane potential. Furthermore, the respiration experi- 
ments in the presence of Ca 2+ and Atr provide proof that 
the oxygen consumption i duced by the Atr specific inducible 
permeability transition can be inhibited by Mi~-CK in the 
presence of Cr and cycloCr (similar to CspA). Neither PCr 
nor GPA has any effect under the conditions we used. The 
isolated and reconstituted brain complexes howed that octa- 
meric Mi~-CK is essential to inhibit the CspA sensitive release 
of malate in the presence of 0400 gM Ca 2+. We believe that 
the complex isolation procedure from solubilised rat brain 
homogenates may selectively enrich Mi~-CK bound to ANT, 
perhaps due to residually bound Cr. A recent small angle X- 
ray scattering study of Mib-CK and MM-CK size upon sub- 
strate binding showed that binding of Mg nucleotides led to a 
marked decrease of the radius of gyration of both MM-CK 
and Mi-CK, leading to a more compact molecular shape, 
whereas Cr had no observable ffect [31]. Therefore, after 
binding of Cr or cycloCr by Mi~-CK, an additional, subtle 
structural change must arise to facilitate the Mi~-CK-ANT 
interaction to occur. GPA feeding for at least 6 weeks has 
been shown to lead to a doubling of BB-CK in mouse [32] 
and rat brains [17], and to increased resistance to hypoxia 
[32]. It would therefore appear from our results that the latter 
protective ffect is due to the increased cytosolic BB-CK pre- 
venting ATP catabolism [32] and not related to permeability 
transition inhibition. Furthermore, permeability transition is 
implicated in myocardial cell, and hepatocyte, injury during 
ischaemia nd reperfusion and cycloCr has been shown to be 
a potent inhibitor of such damage in cardiac tissue, whereas 
Cr was not [33,34]. We propose that this specific cycloCr effect 
may lock the Mi-CK-ANT complex into a permeability tran- 
sition inhibitory conformation more effectively than Cr. This 
could occur as cycloCr is phosphorylated at a 30-fold slower 
rate than Cr [27,35]. The reported effect of Cr and cycloCr in 
inhibiting permeability transition opening and consequently 
the mitochondrial events initiating apoptosis [8] may be rele- 
vant clinically in the future, considering the potential of Cr 
supplementation as an adjuvant herapy for a number of neu- 
romuscular degenerative diseases [36,37]. 
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